Phase I/II Trial of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma and Acquired Resistance to Erlotinib

Title
Phase I/II Trial of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma and Acquired Resistance to Erlotinib
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 17, Issue 8, Pages 2521-2527
Publisher
American Association for Cancer Research (AACR)
Online
2011-01-20
DOI
10.1158/1078-0432.ccr-10-2662

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started